nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—Fibrosis—Carmustine—malignant glioma	0.0161	0.0492	CcSEcCtD
Niacin—QPRT—central nervous system—malignant glioma	0.0145	0.0792	CbGeAlD
Niacin—QPRT—brain—malignant glioma	0.0115	0.0629	CbGeAlD
Niacin—NNMT—medulla oblongata—malignant glioma	0.00942	0.0516	CbGeAlD
Niacin—SLC16A3—brainstem—malignant glioma	0.00922	0.0506	CbGeAlD
Niacin—Faecal incontinence—Carmustine—malignant glioma	0.00912	0.0279	CcSEcCtD
Niacin—SLC16A3—retina—malignant glioma	0.0089	0.0488	CbGeAlD
Niacin—Faecal incontinence—Temozolomide—malignant glioma	0.00882	0.0269	CcSEcCtD
Niacin—NNMT—midbrain—malignant glioma	0.00861	0.0472	CbGeAlD
Niacin—NNMT—spinal cord—malignant glioma	0.0084	0.046	CbGeAlD
Niacin—SLC16A3—telencephalon—malignant glioma	0.00819	0.0449	CbGeAlD
Niacin—Skin hyperpigmentation—Carmustine—malignant glioma	0.00774	0.0237	CcSEcCtD
Niacin—Myasthenia—Carmustine—malignant glioma	0.00733	0.0224	CcSEcCtD
Niacin—Hypokinesia—Carmustine—malignant glioma	0.00682	0.0208	CcSEcCtD
Niacin—NNMT—central nervous system—malignant glioma	0.00681	0.0373	CbGeAlD
Niacin—NNMT—cerebellum—malignant glioma	0.00666	0.0365	CbGeAlD
Niacin—Burning sensation—Carmustine—malignant glioma	0.00663	0.0203	CcSEcCtD
Niacin—SLC16A3—medulla oblongata—malignant glioma	0.00643	0.0353	CbGeAlD
Niacin—Myopathy—Temozolomide—malignant glioma	0.00634	0.0194	CcSEcCtD
Niacin—Lung disorder—Temozolomide—malignant glioma	0.00629	0.0192	CcSEcCtD
Niacin—Hepatotoxicity—Carmustine—malignant glioma	0.00596	0.0182	CcSEcCtD
Niacin—Herpes zoster—Temozolomide—malignant glioma	0.00591	0.0181	CcSEcCtD
Niacin—Necrosis—Carmustine—malignant glioma	0.00587	0.0179	CcSEcCtD
Niacin—Cholestasis—Temozolomide—malignant glioma	0.00586	0.0179	CcSEcCtD
Niacin—Hepatotoxicity—Temozolomide—malignant glioma	0.00576	0.0176	CcSEcCtD
Niacin—NNMT—brain—malignant glioma	0.00541	0.0297	CbGeAlD
Niacin—SLC16A1—retina—malignant glioma	0.00541	0.0296	CbGeAlD
Niacin—Breast pain—Temozolomide—malignant glioma	0.0051	0.0156	CcSEcCtD
Niacin—SLC16A1—telencephalon—malignant glioma	0.00497	0.0273	CbGeAlD
Niacin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00489	0.015	CcSEcCtD
Niacin—SLC16A3—central nervous system—malignant glioma	0.00465	0.0255	CbGeAlD
Niacin—SLC16A3—cerebellum—malignant glioma	0.00455	0.0249	CbGeAlD
Niacin—Vaginal inflammation—Temozolomide—malignant glioma	0.00445	0.0136	CcSEcCtD
Niacin—Skin exfoliation—Carmustine—malignant glioma	0.0044	0.0134	CcSEcCtD
Niacin—SLCO2B1—telencephalon—malignant glioma	0.00428	0.0235	CbGeAlD
Niacin—Skin exfoliation—Temozolomide—malignant glioma	0.00425	0.013	CcSEcCtD
Niacin—Vaginal infection—Temozolomide—malignant glioma	0.0042	0.0128	CcSEcCtD
Niacin—Abnormal vision—Carmustine—malignant glioma	0.00402	0.0123	CcSEcCtD
Niacin—SLC16A1—medulla oblongata—malignant glioma	0.00391	0.0214	CbGeAlD
Niacin—Abnormal vision—Temozolomide—malignant glioma	0.00388	0.0119	CcSEcCtD
Niacin—Diabetes mellitus—Carmustine—malignant glioma	0.00384	0.0117	CcSEcCtD
Niacin—SLC16A3—brain—malignant glioma	0.00369	0.0203	CbGeAlD
Niacin—SLC16A1—midbrain—malignant glioma	0.00357	0.0196	CbGeAlD
Niacin—SLC16A1—spinal cord—malignant glioma	0.00348	0.0191	CbGeAlD
Niacin—SLCO2B1—medulla oblongata—malignant glioma	0.00336	0.0184	CbGeAlD
Niacin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00334	0.0102	CcSEcCtD
Niacin—Face oedema—Carmustine—malignant glioma	0.00323	0.00986	CcSEcCtD
Niacin—Face oedema—Temozolomide—malignant glioma	0.00312	0.00953	CcSEcCtD
Niacin—SLC22A5—retina—malignant glioma	0.00309	0.0169	CbGeAlD
Niacin—Liver function test abnormal—Carmustine—malignant glioma	0.00309	0.00943	CcSEcCtD
Niacin—SLCO2B1—spinal cord—malignant glioma	0.003	0.0164	CbGeAlD
Niacin—Dry skin—Temozolomide—malignant glioma	0.00296	0.00905	CcSEcCtD
Niacin—Muscular weakness—Carmustine—malignant glioma	0.00295	0.00901	CcSEcCtD
Niacin—Dysphagia—Carmustine—malignant glioma	0.00289	0.00883	CcSEcCtD
Niacin—Muscular weakness—Temozolomide—malignant glioma	0.00285	0.0087	CcSEcCtD
Niacin—SLC16A1—central nervous system—malignant glioma	0.00283	0.0155	CbGeAlD
Niacin—Abdominal distension—Temozolomide—malignant glioma	0.00281	0.00859	CcSEcCtD
Niacin—Dysphagia—Temozolomide—malignant glioma	0.00279	0.00853	CcSEcCtD
Niacin—SLC16A1—cerebellum—malignant glioma	0.00276	0.0151	CbGeAlD
Niacin—Bronchitis—Temozolomide—malignant glioma	0.00268	0.0082	CcSEcCtD
Niacin—Erectile dysfunction—Temozolomide—malignant glioma	0.00257	0.00786	CcSEcCtD
Niacin—Stomatitis—Carmustine—malignant glioma	0.00251	0.00767	CcSEcCtD
Niacin—SLCO2B1—central nervous system—malignant glioma	0.00243	0.0133	CbGeAlD
Niacin—Stomatitis—Temozolomide—malignant glioma	0.00243	0.00741	CcSEcCtD
Niacin—SLCO2B1—cerebellum—malignant glioma	0.00238	0.013	CbGeAlD
Niacin—Salicylic acid—PTGS1—malignant glioma	0.00234	0.636	CrCbGaD
Niacin—Haemoglobin—Carmustine—malignant glioma	0.00232	0.0071	CcSEcCtD
Niacin—Haemorrhage—Carmustine—malignant glioma	0.00231	0.00707	CcSEcCtD
Niacin—Hypoaesthesia—Carmustine—malignant glioma	0.0023	0.00703	CcSEcCtD
Niacin—Oedema peripheral—Carmustine—malignant glioma	0.00228	0.00696	CcSEcCtD
Niacin—Haemoglobin—Temozolomide—malignant glioma	0.00225	0.00686	CcSEcCtD
Niacin—SLC16A1—brain—malignant glioma	0.00224	0.0123	CbGeAlD
Niacin—Haemorrhage—Temozolomide—malignant glioma	0.00223	0.00683	CcSEcCtD
Niacin—Hepatitis—Temozolomide—malignant glioma	0.00223	0.00683	CcSEcCtD
Niacin—SLC22A5—medulla oblongata—malignant glioma	0.00223	0.0122	CbGeAlD
Niacin—Visual impairment—Carmustine—malignant glioma	0.00223	0.00681	CcSEcCtD
Niacin—Hypoaesthesia—Temozolomide—malignant glioma	0.00222	0.00679	CcSEcCtD
Niacin—Oedema peripheral—Temozolomide—malignant glioma	0.0022	0.00673	CcSEcCtD
Niacin—Eye disorder—Carmustine—malignant glioma	0.00216	0.0066	CcSEcCtD
Niacin—Visual impairment—Temozolomide—malignant glioma	0.00215	0.00658	CcSEcCtD
Niacin—Flushing—Carmustine—malignant glioma	0.00215	0.00656	CcSEcCtD
Niacin—Eye disorder—Temozolomide—malignant glioma	0.00209	0.00638	CcSEcCtD
Niacin—Tinnitus—Temozolomide—malignant glioma	0.00208	0.00637	CcSEcCtD
Niacin—Flushing—Temozolomide—malignant glioma	0.00207	0.00634	CcSEcCtD
Niacin—CYP2D6—brainstem—malignant glioma	0.00207	0.0113	CbGeAlD
Niacin—Arrhythmia—Carmustine—malignant glioma	0.00207	0.00631	CcSEcCtD
Niacin—Alopecia—Carmustine—malignant glioma	0.00204	0.00624	CcSEcCtD
Niacin—SLC22A5—midbrain—malignant glioma	0.00204	0.0112	CbGeAlD
Niacin—Angiopathy—Temozolomide—malignant glioma	0.00203	0.00619	CcSEcCtD
Niacin—Erythema—Carmustine—malignant glioma	0.00201	0.00615	CcSEcCtD
Niacin—Malnutrition—Carmustine—malignant glioma	0.00201	0.00615	CcSEcCtD
Niacin—Chills—Temozolomide—malignant glioma	0.002	0.00613	CcSEcCtD
Niacin—SLC22A5—spinal cord—malignant glioma	0.00199	0.0109	CbGeAlD
Niacin—Alopecia—Temozolomide—malignant glioma	0.00197	0.00603	CcSEcCtD
Niacin—Erythema—Temozolomide—malignant glioma	0.00195	0.00594	CcSEcCtD
Niacin—Malnutrition—Temozolomide—malignant glioma	0.00195	0.00594	CcSEcCtD
Niacin—SLCO2B1—brain—malignant glioma	0.00193	0.0106	CbGeAlD
Niacin—Vision blurred—Carmustine—malignant glioma	0.0019	0.0058	CcSEcCtD
Niacin—CYP2D6—telencephalon—malignant glioma	0.00183	0.0101	CbGeAlD
Niacin—Vision blurred—Temozolomide—malignant glioma	0.00183	0.0056	CcSEcCtD
Niacin—Leukopenia—Carmustine—malignant glioma	0.0018	0.00551	CcSEcCtD
Niacin—Angioedema—Temozolomide—malignant glioma	0.00178	0.00543	CcSEcCtD
Niacin—Vertigo—Temozolomide—malignant glioma	0.00175	0.00534	CcSEcCtD
Niacin—Leukopenia—Temozolomide—malignant glioma	0.00174	0.00532	CcSEcCtD
Niacin—Palpitations—Temozolomide—malignant glioma	0.00172	0.00525	CcSEcCtD
Niacin—Myalgia—Carmustine—malignant glioma	0.00171	0.00524	CcSEcCtD
Niacin—Cough—Temozolomide—malignant glioma	0.0017	0.00519	CcSEcCtD
Niacin—Myalgia—Temozolomide—malignant glioma	0.00166	0.00506	CcSEcCtD
Niacin—Arthralgia—Temozolomide—malignant glioma	0.00166	0.00506	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00164	0.00503	CcSEcCtD
Niacin—Oedema—Carmustine—malignant glioma	0.00164	0.00502	CcSEcCtD
Niacin—Dry mouth—Temozolomide—malignant glioma	0.00162	0.00495	CcSEcCtD
Niacin—Tachycardia—Carmustine—malignant glioma	0.0016	0.0049	CcSEcCtD
Niacin—Oedema—Temozolomide—malignant glioma	0.00159	0.00485	CcSEcCtD
Niacin—Anaphylactic shock—Temozolomide—malignant glioma	0.00159	0.00485	CcSEcCtD
Niacin—SLC22A5—cerebellum—malignant glioma	0.00158	0.00865	CbGeAlD
Niacin—Anorexia—Carmustine—malignant glioma	0.00157	0.00478	CcSEcCtD
Niacin—Skin disorder—Temozolomide—malignant glioma	0.00154	0.00471	CcSEcCtD
Niacin—Hypotension—Carmustine—malignant glioma	0.00153	0.00469	CcSEcCtD
Niacin—Hyperhidrosis—Temozolomide—malignant glioma	0.00153	0.00469	CcSEcCtD
Niacin—Anorexia—Temozolomide—malignant glioma	0.00151	0.00462	CcSEcCtD
Niacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0015	0.00457	CcSEcCtD
Niacin—Insomnia—Carmustine—malignant glioma	0.00149	0.00454	CcSEcCtD
Niacin—Paraesthesia—Carmustine—malignant glioma	0.00148	0.00451	CcSEcCtD
Niacin—Dyspnoea—Carmustine—malignant glioma	0.00146	0.00448	CcSEcCtD
Niacin—Somnolence—Carmustine—malignant glioma	0.00146	0.00446	CcSEcCtD
Niacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00145	0.00442	CcSEcCtD
Niacin—Insomnia—Temozolomide—malignant glioma	0.00144	0.00439	CcSEcCtD
Niacin—Decreased appetite—Carmustine—malignant glioma	0.00143	0.00436	CcSEcCtD
Niacin—Paraesthesia—Temozolomide—malignant glioma	0.00143	0.00436	CcSEcCtD
Niacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00142	0.00433	CcSEcCtD
Niacin—Dyspnoea—Temozolomide—malignant glioma	0.00142	0.00432	CcSEcCtD
Niacin—Somnolence—Temozolomide—malignant glioma	0.00141	0.00431	CcSEcCtD
Niacin—Pain—Carmustine—malignant glioma	0.0014	0.00429	CcSEcCtD
Niacin—Dyspepsia—Temozolomide—malignant glioma	0.0014	0.00427	CcSEcCtD
Niacin—Decreased appetite—Temozolomide—malignant glioma	0.00138	0.00422	CcSEcCtD
Niacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00137	0.00419	CcSEcCtD
Niacin—Pain—Temozolomide—malignant glioma	0.00136	0.00415	CcSEcCtD
Niacin—Gastrointestinal pain—Carmustine—malignant glioma	0.00134	0.0041	CcSEcCtD
Niacin—Salicylic acid—PTGS2—malignant glioma	0.00134	0.364	CrCbGaD
Niacin—Abdominal pain—Carmustine—malignant glioma	0.0013	0.00397	CcSEcCtD
Niacin—Body temperature increased—Carmustine—malignant glioma	0.0013	0.00397	CcSEcCtD
Niacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.0013	0.00397	CcSEcCtD
Niacin—SLC22A5—brain—malignant glioma	0.00128	0.00703	CbGeAlD
Niacin—Urticaria—Temozolomide—malignant glioma	0.00126	0.00385	CcSEcCtD
Niacin—Abdominal pain—Temozolomide—malignant glioma	0.00125	0.00383	CcSEcCtD
Niacin—Body temperature increased—Temozolomide—malignant glioma	0.00125	0.00383	CcSEcCtD
Niacin—Hypersensitivity—Carmustine—malignant glioma	0.00121	0.0037	CcSEcCtD
Niacin—Asthenia—Carmustine—malignant glioma	0.00118	0.0036	CcSEcCtD
Niacin—Hypersensitivity—Temozolomide—malignant glioma	0.00117	0.00357	CcSEcCtD
Niacin—Asthenia—Temozolomide—malignant glioma	0.00114	0.00348	CcSEcCtD
Niacin—Diarrhoea—Carmustine—malignant glioma	0.00112	0.00343	CcSEcCtD
Niacin—Pruritus—Temozolomide—malignant glioma	0.00112	0.00343	CcSEcCtD
Niacin—Dizziness—Carmustine—malignant glioma	0.00109	0.00332	CcSEcCtD
Niacin—Diarrhoea—Temozolomide—malignant glioma	0.00109	0.00332	CcSEcCtD
Niacin—Dizziness—Temozolomide—malignant glioma	0.00105	0.00321	CcSEcCtD
Niacin—Vomiting—Carmustine—malignant glioma	0.00104	0.00319	CcSEcCtD
Niacin—CYP2D6—central nervous system—malignant glioma	0.00104	0.00571	CbGeAlD
Niacin—Rash—Carmustine—malignant glioma	0.00104	0.00317	CcSEcCtD
Niacin—Dermatitis—Carmustine—malignant glioma	0.00103	0.00316	CcSEcCtD
Niacin—Headache—Carmustine—malignant glioma	0.00103	0.00314	CcSEcCtD
Niacin—CYP2D6—cerebellum—malignant glioma	0.00102	0.00558	CbGeAlD
Niacin—Vomiting—Temozolomide—malignant glioma	0.00101	0.00308	CcSEcCtD
Niacin—Rash—Temozolomide—malignant glioma	0.001	0.00306	CcSEcCtD
Niacin—Dermatitis—Temozolomide—malignant glioma	0.001	0.00306	CcSEcCtD
Niacin—Headache—Temozolomide—malignant glioma	0.000994	0.00304	CcSEcCtD
Niacin—Nausea—Carmustine—malignant glioma	0.000976	0.00298	CcSEcCtD
Niacin—Nausea—Temozolomide—malignant glioma	0.000943	0.00288	CcSEcCtD
Niacin—CYP2D6—brain—malignant glioma	0.000827	0.00454	CbGeAlD
Niacin—SLC16A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000307	0.00063	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CD—malignant glioma	0.000305	0.000627	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000305	0.000626	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT2—malignant glioma	0.000303	0.000623	CbGpPWpGaD
Niacin—NNMT—Metabolism—CAV1—malignant glioma	0.000302	0.00062	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000302	0.00062	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTK2—malignant glioma	0.000298	0.000613	CbGpPWpGaD
Niacin—QPRT—Disease—FGF2—malignant glioma	0.000297	0.000611	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000297	0.00061	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CG—malignant glioma	0.000296	0.000608	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP3—malignant glioma	0.000294	0.000603	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HES1—malignant glioma	0.000293	0.000602	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CB—malignant glioma	0.000293	0.000602	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CD—malignant glioma	0.000291	0.000598	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NCOR1—malignant glioma	0.000291	0.000598	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN2B—malignant glioma	0.000291	0.000598	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KNG1—malignant glioma	0.000289	0.000594	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCAN—malignant glioma	0.000289	0.000593	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—RAF1—malignant glioma	0.000287	0.00059	CbGpPWpGaD
Niacin—QPRT—Metabolism—PPARG—malignant glioma	0.000286	0.000587	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTT1—malignant glioma	0.000284	0.000584	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL2—malignant glioma	0.000284	0.000583	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA2—malignant glioma	0.000283	0.000582	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTK2—malignant glioma	0.000283	0.000581	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000282	0.000579	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—malignant glioma	0.000281	0.000578	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CB—malignant glioma	0.00028	0.000576	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PDGFRA—malignant glioma	0.000279	0.000573	CbGpPWpGaD
Niacin—QPRT—Disease—MDM2—malignant glioma	0.000278	0.000572	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HES1—malignant glioma	0.000278	0.000571	CbGpPWpGaD
Niacin—QPRT—Disease—RAF1—malignant glioma	0.000277	0.00057	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NCOR1—malignant glioma	0.000276	0.000567	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CG—malignant glioma	0.000275	0.000565	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—malignant glioma	0.000274	0.000564	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—RAF1—malignant glioma	0.000272	0.00056	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SPP1—malignant glioma	0.000271	0.000556	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CB—malignant glioma	0.000271	0.000556	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL8—malignant glioma	0.00027	0.000554	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—malignant glioma	0.000269	0.000553	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SOD1—malignant glioma	0.000269	0.000552	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—malignant glioma	0.000268	0.000551	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000268	0.000551	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS1—malignant glioma	0.000266	0.000547	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CB—malignant glioma	0.000266	0.000546	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—malignant glioma	0.000265	0.000545	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PDGFRA—malignant glioma	0.000264	0.000543	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000264	0.000542	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CD—malignant glioma	0.00026	0.000534	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—RAF1—malignant glioma	0.00026	0.000534	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—malignant glioma	0.000258	0.000529	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SPP1—malignant glioma	0.000257	0.000527	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—malignant glioma	0.000257	0.000527	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL8—malignant glioma	0.000256	0.000525	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CB—malignant glioma	0.000254	0.000522	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PDGFB—malignant glioma	0.00025	0.000515	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.00025	0.000513	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGFR1—malignant glioma	0.000249	0.000512	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—BCHE—malignant glioma	0.000247	0.000508	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PTK2—malignant glioma	0.000247	0.000507	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HIF1A—malignant glioma	0.000245	0.000504	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC5A5—malignant glioma	0.000244	0.000502	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—malignant glioma	0.000244	0.000502	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TERT—malignant glioma	0.000243	0.0005	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000242	0.000498	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CD—malignant glioma	0.000242	0.000497	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PDGFB—malignant glioma	0.000237	0.000488	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CAV1—malignant glioma	0.000237	0.000488	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGFR1—malignant glioma	0.000236	0.000485	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KDR—malignant glioma	0.000235	0.000482	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000234	0.000481	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—malignant glioma	0.000234	0.000481	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—malignant glioma	0.000233	0.000479	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HIF1A—malignant glioma	0.000233	0.000478	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH2—malignant glioma	0.000233	0.000478	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000231	0.000474	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CB—malignant glioma	0.000227	0.000466	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—F2—malignant glioma	0.000226	0.000464	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FN1—malignant glioma	0.000226	0.000464	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000225	0.000462	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CAV1—malignant glioma	0.000225	0.000462	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—malignant glioma	0.000225	0.000462	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BAD—malignant glioma	0.000223	0.000459	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—malignant glioma	0.000223	0.000457	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH1—malignant glioma	0.000221	0.000454	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2B6—malignant glioma	0.000219	0.000449	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CD80—malignant glioma	0.000217	0.000445	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—malignant glioma	0.000216	0.000444	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—malignant glioma	0.000216	0.000444	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—F2—malignant glioma	0.000214	0.00044	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FN1—malignant glioma	0.000214	0.00044	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGF—malignant glioma	0.000214	0.000439	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTPN11—malignant glioma	0.000212	0.000437	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BAD—malignant glioma	0.000212	0.000435	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CB—malignant glioma	0.000211	0.000433	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH1—malignant glioma	0.00021	0.000431	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—malignant glioma	0.000209	0.00043	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—malignant glioma	0.000209	0.000429	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PDGFB—malignant glioma	0.000207	0.000426	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CD80—malignant glioma	0.000205	0.000422	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—malignant glioma	0.000205	0.000421	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CG—malignant glioma	0.000205	0.000421	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—malignant glioma	0.000203	0.000418	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGF—malignant glioma	0.000203	0.000416	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTPN11—malignant glioma	0.000201	0.000414	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH1—malignant glioma	0.0002	0.000411	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—malignant glioma	0.000198	0.000407	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT2—malignant glioma	0.000198	0.000407	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—malignant glioma	0.000197	0.000405	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—malignant glioma	0.000197	0.000404	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CAV1—malignant glioma	0.000196	0.000404	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—malignant glioma	0.000196	0.000403	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—malignant glioma	0.000194	0.000399	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SPHK1—malignant glioma	0.000194	0.000398	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—malignant glioma	0.000193	0.000396	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAT—malignant glioma	0.000192	0.000394	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—malignant glioma	0.00019	0.000391	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—malignant glioma	0.00019	0.000391	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2C18—malignant glioma	0.00019	0.00039	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000188	0.000387	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT2—malignant glioma	0.000188	0.000385	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—F2—malignant glioma	0.000187	0.000384	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—FN1—malignant glioma	0.000187	0.000384	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—malignant glioma	0.000187	0.000384	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—malignant glioma	0.000186	0.000382	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—malignant glioma	0.000182	0.000374	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGF2—malignant glioma	0.000182	0.000374	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NCOR1—malignant glioma	0.000181	0.000372	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—malignant glioma	0.00018	0.00037	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—malignant glioma	0.00018	0.000369	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—malignant glioma	0.000179	0.000368	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—malignant glioma	0.000178	0.000367	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EGF—malignant glioma	0.000177	0.000363	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—malignant glioma	0.000176	0.000363	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PTPN11—malignant glioma	0.000176	0.000361	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000175	0.00036	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000173	0.000356	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGF2—malignant glioma	0.000173	0.000355	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000171	0.000351	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000171	0.000351	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MDM2—malignant glioma	0.00017	0.00035	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RAF1—malignant glioma	0.00017	0.000349	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—malignant glioma	0.000168	0.000346	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—malignant glioma	0.000168	0.000345	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—malignant glioma	0.000166	0.00034	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—malignant glioma	0.000165	0.000339	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT2—malignant glioma	0.000164	0.000336	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—malignant glioma	0.000162	0.000333	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—malignant glioma	0.000161	0.000332	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RAF1—malignant glioma	0.000161	0.000331	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—malignant glioma	0.000159	0.000327	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—malignant glioma	0.000159	0.000327	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—malignant glioma	0.000157	0.000323	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—malignant glioma	0.000157	0.000323	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—malignant glioma	0.000155	0.000318	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—malignant glioma	0.000154	0.000316	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—malignant glioma	0.000153	0.000315	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—malignant glioma	0.000152	0.000313	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—malignant glioma	0.000152	0.000313	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—malignant glioma	0.000151	0.00031	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—malignant glioma	0.00015	0.000308	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAV1—malignant glioma	0.000147	0.000303	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—malignant glioma	0.000146	0.0003	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—malignant glioma	0.000144	0.000297	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—malignant glioma	0.000144	0.000296	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—malignant glioma	0.000144	0.000296	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS1—malignant glioma	0.000144	0.000295	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—malignant glioma	0.000143	0.000294	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAF1—malignant glioma	0.00014	0.000288	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—malignant glioma	0.00014	0.000287	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—malignant glioma	0.000138	0.000284	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—malignant glioma	0.000137	0.000282	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000137	0.000281	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—malignant glioma	0.000137	0.000281	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—malignant glioma	0.000136	0.000279	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—malignant glioma	0.000135	0.000277	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—malignant glioma	0.000134	0.000276	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCHE—malignant glioma	0.000134	0.000275	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—malignant glioma	0.000132	0.000272	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—malignant glioma	0.000132	0.000271	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—malignant glioma	0.00013	0.000266	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—malignant glioma	0.000129	0.000266	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—malignant glioma	0.000128	0.000264	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—malignant glioma	0.000128	0.000263	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—malignant glioma	0.000126	0.00026	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—malignant glioma	0.000126	0.000259	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—malignant glioma	0.000123	0.000252	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.00025	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—malignant glioma	0.000121	0.000249	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—malignant glioma	0.000119	0.000244	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—malignant glioma	0.000118	0.000243	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—malignant glioma	0.000116	0.000239	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—malignant glioma	0.000113	0.000232	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—malignant glioma	0.000113	0.000232	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—malignant glioma	0.00011	0.000227	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—malignant glioma	0.00011	0.000226	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—malignant glioma	0.000107	0.00022	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—malignant glioma	0.000106	0.000218	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—malignant glioma	0.000105	0.000216	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000105	0.000215	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—malignant glioma	0.000104	0.000214	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAT—malignant glioma	0.000103	0.000213	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—malignant glioma	0.000103	0.000211	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—malignant glioma	0.000102	0.00021	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—malignant glioma	0.000101	0.000208	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COX8A—malignant glioma	0.000101	0.000207	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—malignant glioma	9.77e-05	0.000201	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOR1—malignant glioma	9.77e-05	0.000201	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—malignant glioma	9.58e-05	0.000197	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—malignant glioma	9.26e-05	0.00019	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—malignant glioma	9.1e-05	0.000187	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—malignant glioma	8.89e-05	0.000183	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ASMT—malignant glioma	8.55e-05	0.000176	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—malignant glioma	8.36e-05	0.000172	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—malignant glioma	8.25e-05	0.00017	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—malignant glioma	8.08e-05	0.000166	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCAN—malignant glioma	8.04e-05	0.000165	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAV1—malignant glioma	7.96e-05	0.000164	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—malignant glioma	7.82e-05	0.000161	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—malignant glioma	7.25e-05	0.000149	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—malignant glioma	7e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—malignant glioma	6.83e-05	0.00014	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH2—malignant glioma	6.48e-05	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—malignant glioma	6.38e-05	0.000131	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—malignant glioma	6.27e-05	0.000129	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2B6—malignant glioma	6.09e-05	0.000125	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH1—malignant glioma	5.57e-05	0.000114	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—malignant glioma	5.56e-05	0.000114	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—malignant glioma	5.51e-05	0.000113	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SPHK1—malignant glioma	5.39e-05	0.000111	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.28e-05	0.000109	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—malignant glioma	5.13e-05	0.000105	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—malignant glioma	4.8e-05	9.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—malignant glioma	4.27e-05	8.78e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS1—malignant glioma	4e-05	8.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCHE—malignant glioma	3.72e-05	7.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.68e-05	7.55e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—malignant glioma	3.39e-05	6.96e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—malignant glioma	2.96e-05	6.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAT—malignant glioma	2.88e-05	5.92e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—malignant glioma	2.77e-05	5.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR1—malignant glioma	2.72e-05	5.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAV1—malignant glioma	2.22e-05	4.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.02e-05	4.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—malignant glioma	1.95e-05	4.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.78e-05	3.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.55e-05	3.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—malignant glioma	1.53e-05	3.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—malignant glioma	1.34e-05	2.75e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.44e-06	1.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—malignant glioma	7.71e-06	1.58e-05	CbGpPWpGaD
